Macrocyclic peptides as HCV NS3 protease inhibitors
Details for Australian Patent Application No. 2006275605 (hide)
International Classifications
Event Publications
21 February 2008 PCT application entered the National Phase
PCT publication WO2007/016441 Priority application(s): WO2007/016441
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
6 January 2011 Application Accepted
Published as AU-B-2006275605
12 May 2011 Standard Patent Sealed
11 October 2012 Alteration of Name
The name of the patentee has been altered to Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006275606-System and method for automatic segmentation of vessels in breast MR sequences
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser